Olysio (Simeprevir) Capsules

Medical Evidence

Generic name : Simeprevir.

Trade name : Olysio.

Manufacturer information :

Olysio is manufactured by Janssen Pharmaceuticals, Inc.

Olysio FDA Approval :

Olysio first approved November 22nd, 2013.

Olysio Dosage form :

Capsule: 150 mg

Olysio Indications and Usage :

Chronic Hepatitis C

Indicated for treatment of chronic hepatitis C genotype 1 infection as a component of a combination antiviral treatment regimen.

Olysio (Simeprevir) availability in India

• You could import this medicine against import permit on Patient Name.
• Please contact ACT Lifesciences Private Limited for further information.